Korea Investment CORP Has $366.39 Million Stake in UnitedHealth Group Incorporated $UNH

Key Points

• Korea Investment CORP has increased its stake in UnitedHealth Group by 1.8%, owning approximately 699,541 shares valued at $366.4 million.
• The company reported a Q2 EPS of $4.08, missing analyst estimates of $4.45, with a revenue of $111.62 billion, slightly below projections.
• UnitedHealth Group announced a quarterly dividend of $2.21 per share, with a yield of 2.9% and a payout ratio of 38.30%.

Korea Investment CORP raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.8% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 699,541 shares of the healthcare conglomerate's stock after buying an additional 12,498 shares during the period. UnitedHealth Group comprises approximately 0.9% of Korea Investment CORP's investment portfolio, making the stock its 16th biggest holding. Korea Investment CORP owned approximately 0.08% of UnitedHealth Group worth $366,385,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC increased its stake in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC increased its stake in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. Jump Financial LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $1,321,000. First Trust Advisors LP increased its stake in shares of UnitedHealth Group by 28.1% during the fourth quarter. First Trust Advisors LP now owns 215,034 shares of the healthcare conglomerate's stock worth $108,777,000 after purchasing an additional 47,174 shares during the period. Finally, Meritage Group LP increased its stake in shares of UnitedHealth Group by 902.5% during the fourth quarter. Meritage Group LP now owns 300,755 shares of the healthcare conglomerate's stock worth $152,140,000 after purchasing an additional 270,755 shares during the period. Institutional investors own 87.86% of the company's stock.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.28% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on UNH shares. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Bank of America increased their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday. Morgan Stanley reduced their price target on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. TD Securities reissued a "hold" rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Mizuho reduced their price target on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Fifteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $367.71.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $4.72 during trading on Tuesday, hitting $303.77. 22,226,972 shares of the company were exchanged, compared to its average volume of 23,411,996. The business's 50 day moving average is $289.03 and its 200-day moving average is $393.55. The company has a market capitalization of $275.12 billion, a P/E ratio of 13.16, a price-to-earnings-growth ratio of 1.99 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm's quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group's payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.